GLPBio

PolQi1

Catalog No.: GC75685Purity:>98.00%
PolQi1 is a selective inhibitor targeting the structure domain of DNA polymerase Polθ.

Products are for research use only. Not for human use. We do not sell to patients.


PolQi1
Cas No.: 2607139-80-8
1mgIn Stock
$130.00
1
5mgIn Stock
$325.00
1
10mgIn Stock
$475.00
1
25mgIn Stock
$748.00
1
50mgIn Stock
$987.00
1
100mgIn Stock
$1,360.00
1
200mgIn Stock
$1,830.00
1

Citations

No citations are currently available for this product. Below are selected publications citing GlpBio products.
  • Nature cover
    Nature
    641, 529–536 (2025)
  • Nature cover
    Nature
    628, 630–638 (2024)
  • Nature cover
    Nature
    632, 686–694 (2024)
  • Nature cover
    Nature
    618, 1017–1023 (2023)
  • Nature cover
    Nature
    610, 366–372 (2022)
  • Cell cover
    Cell
    187(9):2288-2304 (2024)
  • Cell cover
    Cell
    183(7):1867-1883 (2020)
  • Science cover
    Science
    388(6745) (2025)
  • Science cover
    Science
    387(6739) (2025)
  • Science cover
    Science
    387(6734) (2025)
  • Cell Research cover
    Cell Research
    35, 97–116 (2025)
  • Cell Research cover
    Cell Research
    34, 683–706 (2024)
  • Cell Research cover
    Cell Research
    33, 273–287 (2023)
  • Cell Research cover
    Cell Research
    33, 546–561 (2023)
  • Cell Research cover
    Cell Research
    33, 904–922 (2023)
  • Cell Research cover
    Cell Research
    31, 1291–1307 (2021)

Description

PolQi1 is a selective inhibitor targeting the structure domain of DNA polymerase Polθ [1]. PolQi1 can target DNA repair pathways to promote homology-directed repair (HDR) by regulating DNA polymerase Polθ[2]. The combination of PolQi1 and AZD7648 can augment the integration efficiency and editing accuracy mediated by HDR, and reduce off-target mutations and translocations[3]. PolQi1 has been widely used to upgrade the accuracy of various genome engineering editing systems and to reduce the off-target editing effects of active nuclease systems [4].

References:
[1] Mentani A, Maresca M, Shiriaeva A. Prime editing: Mechanistic insights and DNA repair modulation[J]. Cells, 2025, 14(4): 277.
[2] Haider S, Mussolino C. Fine-tuning homology-directed repair (HDR) for precision genome editing: current strategies and future directions[J]. International Journal of Molecular Sciences, 2025, 26(9): 4067.
[3] Wimberger S, Akrap N, Firth M, et al. Simultaneous inhibition of DNA-PK and Polϴ improves integration efficiency and precision of genome editing[J]. Nature communications, 2023, 14(1): 4761.
[4] Dacquay L C, Antoniou P, Mentani A, et al. Dual inhibition of DNA-PK and Polϴ boosts precision of diverse prime editing systems[J]. Nature Communications, 2025, 16(1): 4290.

Product Documents

Purity:>98.00%Appearance:A solid

Chemical Properties

CAS No.
2607139-80-8
Molecular Formula
C18H14ClF5N4O2
Molecular Weight
448.77
Solubility
DMSO: 100 mg/mL (222.83 mM; Need ultrasonic)
Storage
-20°C
General tips
Select a suitable solvent according to the product solubility data. Once prepared, aliquot the stock solution to avoid repeated freeze-thaw cycles.
Use stock solutions within 6 months when stored at -80°C or within 1 month when stored at -20°C.
To improve solubility, warm the tube to 37°C and sonicate it for an appropriate period.
Shipping Condition
Evaluation samples are shipped with blue ice. Other available sizes are shipped at room temperature or with blue ice upon request.

CalculatorsMolarity / Dilution / Molecular Weight / Unit Conversion / In Vivo Formulation / Solubility

g/mol

Reviews

Review for PolQi1

Rating: 5
  • 5 Star100%
  • 4 Star0%
  • 3 Star0%
  • 2 Star0%
  • 1 Star0%